Incidence of colorectal adenomas: Birth cohort analysis among 4.3 million participants of screening colonoscopy

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 9, 2014, Pages 1920-1927

  Brenner, Hermann ^a   Altenhofen, Lutz ^b   Stock, Christian ^a,c   Hoffmeister, Michael ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Central Research Institute of Ambulatory Health Care in Germany   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL ADENOMA; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEX DIFFERENCE; ADENOMA; AGE; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; GERMANY; INCIDENCE; MASS SCREENING; MIDDLE AGED; PROCEDURES;

ADENOMA; AGE FACTORS; AGED; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; SEX FACTORS;

EID: 84907184693     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0367     Document Type: Article

References (35)

1. Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenomacarcinoma sequence. Br J Surg 2002; 89: 845-90.
2. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2014; 383: 1490-502.
3. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic reviewof colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008; 103: 1541-9.
4. Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2012; 9: e1001352.
5. Doubeni CA, Weinman S, Adams K, Kamineni A, Buist DSM, Ash AS, et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults. Ann Intern Med 2013; 158: 312-20.
6. Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M. Reduced risk of colorectal cancer up to 10 years after screening, surveillance or diagnostic colonoscopy. Gastroenterology 2014; 146; 709-17.
7. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013; 369: 1095-105.
8. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 1982; 49: 819-25.
9. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982; 23: 835-42.
10. Kuntz KM, Lansdorp-Vogelaar I, Rutter CM, Knudsen AB, van Ballegooijen M, Savarino JE, et al. A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making 2011; 31: 530-9.
11. Van Ballegooijen M, Rutter CM, Knudsen AB, Zauber AG, Savarino JE, Lansdorp-Vogelaar I, et al. Clarifying differences in natural history between models of screening: the case of colorectal cancer. Med Decis Making 2011; 31: 540-9.
12. Brenner H, Altenhofen L, Stock C, Hoffmeister M. Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy. Cancer Epidemiol Biomarkers Prev 2013; 22: 1043-51.
13. Pox C, Altenhofen L, Brenner H, Theilmeier A, von Stillfried D, Schmiegel W. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 2012; 142: 1460-7.
14. Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hoffmeister M. Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database. Am J Epidemiol 2011; 174: 1140-6.
15. Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (GEKID). GEKID Atlas. [last accessed 2014 Mar 21]. Available from: http://www.gekid.de/.
16. Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006; 355: 1863-72.
17. Nguyen SP, Bent S, Chen YH, Terdiman JP. Gender as a risk factor for advanced neoplasia and colorectal cancer. A systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009; 7: 676-81.
18. Brenner H, Altenhofen L, Hoffmeister M. Sex, age and birth cohort effects in colorectal neoplasms: a cohort analysis. Ann Intern Med 2010; 102: 1411-4.
19. Brenner H, Hoffmeister M, Arndt V, Haug U. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer 2007; 96: 828-31.
20. Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol 2014; 12: 478-85.
21. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. JAMA 2008; 300: 2765-78.
22. Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E, et al. Red and processed meat and colorectal cancer incidence: metaanalysis of prospective studies. PLoS ONE 2011; 6: e20456.
23. Chen MJ, Longnecker MP, Morgenstern H, Lee ER, Frankl HD, Haile RW. Recent use of hormone replacement therapy and the prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 1998; 7: 227-30.
24. Grodstein F, Martinez ME, Platz EA, Giovannucci E, Colditz GA, Kautzky M, et al. Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med 1998; 128: 705-12.
25. Terry MB, Neugut AI, Bostick RM, Sandler RS, Haile RW, Jacobson JS, et al. Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2002; 11: 622-9.
26. Purdue MP, Mink PJ, Hartge P, Huang WY, Buys S, Hayes RB. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Cancer Causes Control 2005; 16: 965-73.
27. Singh H, Turner D, Xue L, Targownik LE, Bernstein CN. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 2006; 295: 2366-73.
28. Lakoff J, Paszat LF, Saskin R, Rabeneck L. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 2008; 6: 1117-21.
29. Brenner H, Chang-Claude J, Seiler CM, Hoffmeister M. Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol 2011; 29: 3761-7.
30. Knudsen AB, Hur C, Gazelle GS, Schrag D, McFarland EG, Kuntz KM. Rescreening of individuals with a negative colonoscopy: a comparative effectiveness analysis. Ann Intern Med 2012; 157: 611-20.
31. Van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006; 101: 343-50.
32. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002; 101: 403-8.
33. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 2010; 102: 89-95.
34. Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013; 62: 367-86.
35. Sweetser S, Smyrk TC, Sinicrope FA. Serrated colon polyps as precursors tocolorectal cancer. ClinGastroenterolHepatol 2013; 11: 760-7.